New CFR Report Outlines How the U.S. Can Reduce Its Pharmaceutical Dependence on China (opens in new tab)

The U.S. pharmaceutical supply chain faces a threat equal to the rare-earths challenge already posed by China’s exploitation of its dominance of those critical minerals. “China has both the tools and demonstrated willingness to weaponize U.S. pharmaceutical dependence: the structural conditions enabling it run through nearly every tier of the pharmaceutical supply,” warns a new […]